Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in J Clin Oncol

Retrieve available abstracts of 16 articles:
HTML format
Text format

Single Articles

    April 2017
  1. CHRISTIE EL, Fereday S, Doig K, Pattnaik S, et al
    Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer.
    J Clin Oncol. 2017;35:1274-1280.
    PubMed     Text format     Abstract available

    February 2017
  2. HUMMEL SB, van Lankveld JJ, Oldenburg HS, Hahn DE, et al
    Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial.
    J Clin Oncol. 2017 Feb 27:JCO2016696021. doi: 10.1200/JCO.2016.69.6021.
    PubMed     Text format     Abstract available

    August 2016
  3. WRIGHT AA, Bohlke K, Armstrong DK, Bookman MA, et al
    Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
    J Clin Oncol. 2016 Aug 8. pii: JCO686907.
    PubMed     Text format     Abstract available

    April 2016
  4. WRIGHT JD, Burke WM, Tergas AI, Hou JY, et al
    Comparative Effectiveness of Minimally Invasive Hysterectomy for Endometrial Cancer.
    J Clin Oncol. 2016;34:1087-96.
    PubMed     Text format     Abstract available

    March 2016
  5. WRIGHT AA, Cronin A, O'Malley DM
    Reply to G.B. Holt.
    J Clin Oncol. 2016;34:1016-7.
    PubMed     Text format    

  6. TUNG N, Lin NU, Kidd J, Allen BA, et al
    Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
    J Clin Oncol. 2016 Mar 14. pii: JCO650747.
    PubMed     Text format     Abstract available

  7. CHAN JK, Monk BJ
    Reply to F.M. Muggia.
    J Clin Oncol. 2016;34:882-3.
    PubMed     Text format    

  8. BOOKMAN MA, Brady MF
    Reply to F.M. Muggia.
    J Clin Oncol. 2016;34:884.
    PubMed     Text format    

  9. SCHRADER KA, Stratton KL, Murali R, Laitman Y, et al
    Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 Variant.
    J Clin Oncol. 2016;34:e61-7.
    PubMed     Text format    

    February 2016
  10. LOPES LF, Macedo CR, Aguiar Sdos S, Barreto JH, et al
    Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
    J Clin Oncol. 2016;34:603-10.
    PubMed     Text format     Abstract available

  11. LAMM W, Schiefer A, Nobauer IM, Horvat R, et al
    Aromatase Inhibitor Therapy As Effective Rescue in a Patient With Tamoxifen-Refractory Metastatic Granulosa Cell Tumor of the Ovary.
    J Clin Oncol. 2016;34:e31-3.
    PubMed     Text format    

    Intraperitoneal Therapy for Ovarian Cancer.
    J Clin Oncol. 2016 Feb 1. pii: JCO628370.
    PubMed     Text format    

    January 2016
    Beautiful Imperfections.
    J Clin Oncol. 2016;34:286-7.
    PubMed     Text format    

  14. PUJADE-LAURAINE E, Selle F, Weber B, Ray-Coquard IL, et al
    Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.
    J Clin Oncol. 2016 Jan 11. pii: JCO621474.
    PubMed     Text format     Abstract available

  15. HOLT GB
    Potential Simpson's Paradox in Multicenter Study of Intraperitoneal Chemotherapy for Ovarian Cancer.
    J Clin Oncol. 2016 Jan 11. pii: JCO644542.
    PubMed     Text format    

    December 2015
  16. RUNOWICZ CD, Leach CR, Henry NL, Henry KS, et al
    American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.
    J Clin Oncol. 2015 Dec 7. pii: JCO.2015.64.3809.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.